Mei Kang

No. 16 Jiangsu Road
Qingdao, 266003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Shepherdin Affects the Biological Behavior of Rhabdomyosarcoma and Enhances its X-Ray Sensitivity.

Shepherdin Affects the Biological Behavior of Rhabdomyosarcoma and Enhances its X-Ray Sensitivity.

Journal: Applied biochemistry and biotechnology

Published: May 02, 2026

Prognostic significance and optimal staging of supraclavicular lymph node metastasis in upper esophageal squamous cell carcinoma undergoing chemoradiotherapy.

Prognostic significance and optimal staging of supraclavicular lymph node metastasis in upper esophageal squamous cell carcinoma undergoing chemoradiotherapy.

Journal: BMC cancer

Published: February 02, 2026

Clinicopathological features and departmental distribution of sarcoma patients: a single-center retrospective study.

Clinicopathological features and departmental distribution of sarcoma patients: a single-center retrospective study.

Journal: BMC cancer

Published: January 03, 2026

Inhibition of radiotherapy sensitivity in nasopharyngeal carcinoma via the long non-coding RNA RHPN1-AS1.

Inhibition of radiotherapy sensitivity in nasopharyngeal carcinoma via the long non-coding RNA RHPN1-AS1.

Journal: Translational cancer research

Published: December 23, 2025

Radical surgery versus definitive radiotherapy in treatment of locoregional upper esophageal squamous cell carcinoma.

Radical surgery versus definitive radiotherapy in treatment of locoregional upper esophageal squamous cell carcinoma.

Journal: BMC cancer

Published: May 17, 2025

Patterns of Lymph Node Recurrence after Esophagectomy of pT2-3 N0M0 Esophageal Squamous Cell Carcinoma.

Patterns of Lymph Node Recurrence after Esophagectomy of pT2-3 N0M0 Esophageal Squamous Cell Carcinoma.

Journal: Journal of gastrointestinal cancer

Published: April 29, 2025

Long-term survival and risk factors in esophageal squamous cell carcinoma: A Kaplan-Meier and cox regression study.

Long-term survival and risk factors in esophageal squamous cell carcinoma: A Kaplan-Meier and cox regression study.

Journal: World journal of gastrointestinal surgery

Published: August 20, 2024

Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study.

Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study.

Journal: BMC cancer

Published: March 29, 2024

Risk factors for postoperative recurrence of pT2-3N0M0 esophageal squamous cell carcinoma and patterns of its recurrence.

Risk factors for postoperative recurrence of pT2-3N0M0 esophageal squamous cell carcinoma and patterns of its recurrence.

Journal: Bioscience trends

Published: December 20, 2023

A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection.

A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection.

Journal: Journal of cancer research and clinical oncology

Published: June 14, 2023

Camrelizumab combined with apatinib in the treatment of patients with hepatocellular carcinoma: a real-world assessment.

Camrelizumab combined with apatinib in the treatment of patients with hepatocellular carcinoma: a real-world assessment.

Journal: Neoplasma

Published: April 13, 2023

Assessing the effectiveness of camrelizumab plus apatinib versus sorafenib for the treatment of primary liver cancer: a single-center retrospective study.

Assessing the effectiveness of camrelizumab plus apatinib versus sorafenib for the treatment of primary liver cancer: a single-center retrospective study.

Journal: Scientific reports

Published: March 01, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026